Trading by management and close relations of management
05. März 2025 03:33 ET
|
Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Initiation of share buyback program
05. März 2025 02:42 ET
|
Novonesis (Novozymes A/S)
On March 5, 2025, Novonesis will initiate a share buyback program as announced in Company Announcement No. 3 of February 26, 2025. Under the program, Novonesis will buy back B shares worth up to EUR...
Trading by management and close relations of management
03. März 2025 06:16 ET
|
Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...
Trading by management and close relations of management
27. Februar 2025 03:39 ET
|
Novonesis (Novozymes A/S)
The Executive Leadership Team members eligible for the Novozymes A/S 2022-2024 incentive program has on February 26, 2025, received the allocated shares. An overview of the number and value of shares...
12M 2024: Novonesis delivers strong full-year results and expects continued growth in 2025
26. Februar 2025 02:04 ET
|
Novonesis (Novozymes A/S)
Novonesis delivers 8% organic sales growth with an adjusted EBITDA margin of 36.1% in 2024. For 2025, Novonesis presents an outlook of 5-8% organic sales growth with an adjusted EBITDA margin of...
12M 2024 Company announcement
26. Februar 2025 01:58 ET
|
Novonesis (Novozymes A/S)
2024 organic pro forma sales growth of 8%, with pro forma adjusted EBITDA margin of 36.1%. 2025 outlook of 5-8% organic pro forma sales growth and 37-38% adjusted EBITDA margin. 2024 organic pro...
Change to the Executive Leadership Team
21. Februar 2025 06:24 ET
|
Novonesis (Novozymes A/S)
Jacob Vishof Paulsen will be leaving his position as Executive Vice President of Food & Beverage Biosolutions, as he has accepted a role outside of Novonesis, effective March 31, 2025. Ester...
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
11. Februar 2025 01:13 ET
|
Novonesis (Novozymes A/S)
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5...
Novonesis to acquire dsm-firmenich’s share of the Feed Enzyme Alliance
11. Februar 2025 00:57 ET
|
Novonesis (Novozymes A/S)
Novonesis has reached an agreement with dsm-firmenich to dissolve the Feed Enzyme Alliance and take over its sales and distribution activities, in exchange for a total cash consideration of EUR 1.5...
Trading by management and close relations of management
03. Januar 2025 05:23 ET
|
Novonesis (Novozymes A/S)
In accordance with article 19 in Regulation (EU) No 596/2014 of 16 April 2014 on market abuse (the Market Abuse Regulation) and commission delegated regulation (EU) 1052/2016 of 8 March 2016,...